Cargando…
Single-cell transcriptome analysis of the heterogeneous effects of differential expression of tumor PD-L1 on responding TCR-T cells
Rationale: TCR-T cell therapy plays a critical role in the treatment of malignant cancers. However, it is unclear how TCR-T cells are affected by PD-L1 molecule in the tumor environment. We performed an in-depth evaluation on how differential expressions of tumor PD-L1 can affect the functionality o...
Autores principales: | Ding, Renpeng, Liu, Shang, Wang, Shanshan, Chen, Huanyi, Wang, Fei, Xu, Qumiao, Zhu, Linnan, Dong, Xuan, Gu, Ying, Zhang, Xiuqing, Chao, Cheng-Chi, Gao, Qianqian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7978322/ https://www.ncbi.nlm.nih.gov/pubmed/33754038 http://dx.doi.org/10.7150/thno.55075 |
Ejemplares similares
-
Single-Cell Transcriptomics Reveals Killing Mechanisms of Antitumor Cytotoxic CD4(+) TCR-T Cells
por: Liang, Yanling, et al.
Publicado: (2022) -
Therapeutic potential of CRISPR/Cas9 gene editing in engineered T‐cell therapy
por: Gao, Qianqian, et al.
Publicado: (2019) -
A single-cell approach to engineer CD8+ T cells targeting cytomegalovirus
por: Wang, Fei, et al.
Publicado: (2020) -
Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumors
por: John, Jessy, et al.
Publicado: (2022) -
TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines
por: Jordan, Kimberly R., et al.
Publicado: (2012)